
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Toshiba America Medical Systems' new entry into the high-fieldMRI scanner segment has received regulatory clearance from theFood and Drug Administration. Visart is a 1.5-tesla scanner thatthe Tustin, CA, company unveiled at last year's Radiological
Toshiba America Medical Systems' new entry into the high-field
MRI scanner segment has received regulatory clearance from the
Food and Drug Administration. Visart is a 1.5-tesla scanner that
the Tustin, CA, company unveiled at last year's Radiological Society
of North America meeting (SCAN 11/22/95).




